Esperion Therap (ESPR) Posts Q1 Loss of 51c/Share

Esperion Therap (NASDAQ: ESPR) reported Q1 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Esperion Therap (ESPR) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy